Commission authorised adapted COVID-19 vaccine for autumn vaccination in the EU
The European Commission has authorised on Thursday the Comirnaty XBB.1.5-adapted COVID-19 vaccine, developed by BioNTech-Pfizer, as a respond to new COVID-19 variants. The vaccine is authorised for adults, children and infants above 6 months, Commissi…